CliffBio
small molecule

FLUTICASONE PROPIONATE

FLUTICASONE PROPIONATE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameFLUTICASONE PROPIONATE
Active ingredientFLUTICASONE PROPIONATE
Strength0.05MG/SPRAY
Dosage formSPRAY, METERED
RouteNASAL
ModalitySmall molecule
FDA approvalSeptember 2007
Marketing statusRX

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.